Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MediPines
AddedFeb 15, 2024
UpdatedJun 18, 2026
MediPines

MediPines

Seed

MediPines Corp: Pioneering advanced respiratory medicine through innovative medical devices.

HQ
Yorba Linda, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

MediPines Corporation, founded with a mission to revolutionize respiratory medicine, focuses on developing innovative medical devices for advanced respiratory care. The company's flagship product, the MediPines AGM100™, provides fast, accurate, and non-invasive assessments of cardiorespiratory status at the point of care. MediPines aims to enhance diagnostic and treatment decisions in respiratory medicine, targeting healthcare providers and institutions that require precise and timely respiratory evaluations.

Notable figures associated with MediPines include leading experts in respiratory medicine and seasoned medical device professionals. The company has garnered attention from prominent investors in the healthcare technology sector. Key achievements include the successful development and deployment of the AGM100™, which has significantly impacted clinical practices by improving patient outcomes through better diagnostic accuracy. MediPines continues to influence the field of respiratory medicine with its cutting-edge solutions, contributing to advancements in patient care and medical technology.

MediPines - Similar Companies

Respiratory Motion logo

Respiratory Motion

Pneuma Respiratory logo

Pneuma Respiratory

MedicaMetrix logo

MedicaMetrix

medicametrix.com

Jan Medical logo

Jan Medical

janmedical.com

White Pine Medical logo

White Pine Medical

Soffio Medical logo

Soffio Medical

soffiomedical.com

Aerin Medical logo

Aerin Medical

Portela Soni Medical logo

Portela Soni Medical

Cactus Medical logo

Cactus Medical

Meditrina logo

Meditrina

Consano Medical logo

Consano Medical

Ativa Medical logo

Ativa Medical

Respiderm logo

Respiderm

Digital Medical Tech logo

Digital Medical Tech

Ventus Medical logo

Ventus Medical

ventusmedical.com

MediPines - Quick Facts

Who are MediPines' competitors?

Companies similar to MediPines include Respiratory Motion, Pneuma Respiratory, MedicaMetrix and Jan Medical.

When was MediPines founded?

MediPines was founded in 2014.

Where is MediPines' headquarters located?

MediPines' headquarters is located in Yorba Linda, CA, US.

When was MediPines' last funding round?

MediPines' most recent funding round was for $3.1M (USD) in September 2021.

How much has MediPines raised to-date?

As of Sep 8, 2021, MediPines has raised a total of $7.4M (USD).

How many employees does MediPines have?

MediPines has 19 employees as of Feb 5, 2024.

MediPines - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified